Making it easier for people to confirm if they are allergic to penicillin
Improving Equitable Access to Penicillin Allergy De-Labeling
This study is looking for ways to help people who think they're allergic to penicillin find out if they really are, so they can get better antibiotics and stay healthier, especially in communities that need more support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11035094 on NIH RePORTER |
What this research studies
This research aims to improve access to penicillin allergy de-labeling, which is the process of confirming whether individuals who believe they are allergic to penicillin actually have a true allergy. Many people mistakenly report a penicillin allergy, leading to the use of less effective antibiotics that can cause more health issues. The project will explore strategies to make this de-labeling process more equitable, particularly for communities that face health disparities. By focusing on proactive measures in outpatient settings, the research seeks to reduce the prevalence of antimicrobial resistance and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been labeled as allergic to penicillin but have not undergone formal testing to confirm this allergy.
Not a fit: Patients who have a confirmed penicillin allergy or those who do not have access to healthcare services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate penicillin allergy assessments, allowing patients to receive better antibiotic treatments and reducing the risk of antimicrobial resistance.
How similar studies have performed: Previous research has shown that de-labeling efforts can improve antibiotic prescribing practices, indicating potential success for this approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Blumenthal, Kimberly Gold — Massachusetts General Hospital
- Study coordinator: Blumenthal, Kimberly Gold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.